Related Experiment Video
Updated: Aug 25, 2025

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Antifungal stewardship in solid-organ transplantation: What is needed?
Laura Whitney1, Darius Armstrong-James2, Haifa S Lyster3
1NHS England and Improvement, London, UK.
Background:
Antifungal stewardship (AFS) lags behind antimicrobial stewardship (AMS) in terms of implementation, evidence base, and workforce experience. Solid-organ transplantation (SOT) carries a significant risk of invasive fungal infection, with high associated mortality, and is therefore associated with significant opportunities to optimize antifungal use.
Methods:
A literature search for the terms "antifungal stewardship" and "solid-organ transplant" revealed a small evidence base to support AFS programs in this patient group.
Results:
There is significant overlap in the methodology used in AMS and AFS programs, with notable differences in diagnostics, which are discussed in detail. The primary AFS interventions tested in SOT recipients are implementation of clinical guidelines and care bundles, digital enablers of AFS, and post-prescription review/audit and feedback.
Conclusion:
There is an urgent need for further research to support effective AFS strategies in this highly susceptible population.
More Related Videos
Related Concept Videos
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Cystic Fibrosis: Management
Sinus disease and chronic...
Kidney Transplant I: Introduction
Fungal Phylum Microsporidia

